LU77353A1 - - Google Patents

Info

Publication number
LU77353A1
LU77353A1 LU77353A LU77353A LU77353A1 LU 77353 A1 LU77353 A1 LU 77353A1 LU 77353 A LU77353 A LU 77353A LU 77353 A LU77353 A LU 77353A LU 77353 A1 LU77353 A1 LU 77353A1
Authority
LU
Luxembourg
Application number
LU77353A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to LU77353A priority Critical patent/LU77353A1/xx
Priority to FR7814338A priority patent/FR2390959A1/fr
Publication of LU77353A1 publication Critical patent/LU77353A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LU77353A 1977-05-16 1977-05-16 LU77353A1 (en:Method)

Priority Applications (2)

Application Number Priority Date Filing Date Title
LU77353A LU77353A1 (en:Method) 1977-05-16 1977-05-16
FR7814338A FR2390959A1 (fr) 1977-05-16 1978-05-12 Association therapeutique a visee anti-agregante et regularisatrice de la duree de vie plaquettaire a base de pyrimido-pyrimidine et d'acide acetyl salycilique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU77353A LU77353A1 (en:Method) 1977-05-16 1977-05-16

Publications (1)

Publication Number Publication Date
LU77353A1 true LU77353A1 (en:Method) 1979-01-19

Family

ID=19728580

Family Applications (1)

Application Number Title Priority Date Filing Date
LU77353A LU77353A1 (en:Method) 1977-05-16 1977-05-16

Country Status (2)

Country Link
FR (1) FR2390959A1 (en:Method)
LU (1) LU77353A1 (en:Method)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2452922A2 (fr) * 1979-04-02 1980-10-31 Panoz Donald Nouvelle forme galenique d'administration de medicaments par voie orale, a liberation programmee
FR2470600A2 (fr) * 1979-12-07 1981-06-12 Panoz Donald Nouvelle forme galenique d'administration de medicaments par voie orale, a liberation programmee
CH647676A5 (fr) * 1978-12-22 1985-02-15 Donald E Panoz Formes galeniques a usage oral, a liberation programmee et leurs procedes de preparation.
FR2452923A2 (fr) * 1979-04-02 1980-10-31 Panoz Donald Nouvelle forme galenique d'administration de medicaments par voie orale, a liberation programmee
FR2453642A1 (fr) * 1979-04-12 1980-11-07 Sanofi Sa Compositions therapeutiques a usage oral et a liberation programmee du methanesulfonate de dihydroergotoxine
FR2454804B1 (fr) * 1979-04-26 1986-11-21 Sanofi Sa Medicament a base de dihydroergotoxine et son procede de preparation
FR2470599A1 (fr) * 1979-12-07 1981-06-12 Panoz Donald Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
DE3000979A1 (de) 1980-01-12 1981-07-23 Dr. Karl Thomae Gmbh, 7950 Biberach Neue dipyridamol-retardformen und verfahren zu ihrer herstellung
FR2492661A1 (fr) * 1980-10-28 1982-04-30 Laruelle Claude Nouvelle forme galenique d'administration du metoclopramide, son procede de preparation et medicament comprenant cette nouvelle forme
EP0052075A1 (de) * 1980-11-12 1982-05-19 Ciba-Geigy Ag Körnige Arzneimittel-Retardform
FR2494112B1 (en:Method) * 1980-11-19 1986-01-10 Laruelle Claude
DE3124090A1 (de) * 1981-06-19 1983-01-05 Dr. Karl Thomae Gmbh, 7950 Biberach Neue orale dipyridamolformen
US4444777A (en) * 1981-07-30 1984-04-24 Bristol-Myers Company Pharmaceutical compositions of anagrelide and sulfinpyrazone
FR2513118A1 (fr) * 1981-09-18 1983-03-25 Rocador Sa Composition pharmaceutique a base de dipyridamol et de sel d'aluminium de l'acide acetylsalicylique pour combattre l'agregation plaquettaire
FR2539995B1 (fr) * 1983-01-28 1985-08-16 Sanofi Sa Medicament a liberation programmee a base d'acide acetylsalicylique
EP0169465B1 (de) * 1984-07-21 1990-02-28 Hoechst Aktiengesellschaft Kombinationspräparat aus Pyrimido-pyrimidinen und O-Acetylsalicylsäure bzw. deren pharmakologisch verträglichen Salzen und dessen Verwendung
DE3627423A1 (de) * 1986-08-13 1988-02-18 Thomae Gmbh Dr K Arzneimittel enthaltend dipyridamol oder mopidamol und o-acetylsalicylsaeure bzw. deren physiologisch vertraegliche salze, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung der thrombusbildung
AT393962B (de) * 1987-10-22 1992-01-10 Thomae Gmbh Dr K Synergistische arzneimittelkombination mit einem gehalt an einem phosphodiesterase-hemmer und derenverwendung
US5041430A (en) * 1989-09-18 1991-08-20 Du Pont Mereck Pharmaceutical Company Oral anticoagulant/platelet inhibitor low dose formulation
FR2681596B1 (fr) * 1991-09-23 1993-11-26 Thomas Andre Procede de preparation d'acetylsalicylates des bases puriques et pyrimidiques et de leurs nucleosides.
WO2010036975A2 (en) * 2008-09-25 2010-04-01 Teva Pharmaceutical Industries Ltd. Dipyridamole and acetylsalicylic acid formulations and process for preparing same

Also Published As

Publication number Publication date
FR2390959B1 (en:Method) 1983-03-25
FR2390959A1 (fr) 1978-12-15

Similar Documents

Publication Publication Date Title
AU3353778A (en:Method)
AR210643A1 (en:Method)
AU495917B2 (en:Method)
AU71461S (en:Method)
BG25815A1 (en:Method)
BG25810A1 (en:Method)
BE866391A (en:Method)
BE868323A (en:Method)
BG25834A1 (en:Method)
BE871419A (en:Method)
BE871991A (en:Method)
BE872973A (en:Method)
BE873002A (en:Method)
BG23438A1 (en:Method)
BG23462A1 (en:Method)
BG24331A1 (en:Method)
BG24713A1 (en:Method)
BG25808A1 (en:Method)
BG25809A1 (en:Method)
BG25823A1 (en:Method)
BG25811A1 (en:Method)
BG25812A1 (en:Method)
BG25813A1 (en:Method)
BG25838A1 (en:Method)
BG25819A1 (en:Method)